G & M LABTESTING INC
NPI 1457036014
Clinical Medical Laboratory in Tujunga, CA
NPI Status: Active since June 20, 2023
Contact Information
7341 FOOTHILL BLVD STE 202
TUJUNGA, CA
ZIP 91042
Phone: (747) 256-9745
- Organization
- Clinical Medical Laboratory
- CLIA Number: 05D2270788
- CLIA Cert. Type: Independent
- CLIA Exp. Date: 05-31-2026
About G & M LABTESTING INC
This page provides the complete NPI Profile along with additional information for G & M Labtesting Inc, a provider established in Tujunga, California operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1457036014 assigned on June 2023. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 3 years ago. The authorized official of this NPI record is Gevorg Hovhannisyan (President)
- NPI
- 1457036014
- Provider Name
- G & M LABTESTING INC
- Entity Type
- Organization
- Location Address
- 7341 FOOTHILL BLVD STE 202 TUJUNGA, CA 91042
- Location Phone
- (747) 256-9745
- Mailing Address
- 7341 FOOTHILL BLVD STE 202 TUJUNGA, CA 91042
- Mailing Phone
- (747) 256-9745
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 06-20-2023
- Last Update Date
- 06-20-2023
- Code Navigator
Establishments like G & M Labtesting Inc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique
Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets
Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique
Detection test by nucleic acid for herpes simplex virus, amplified probe technique
Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
Detection test by nucleic acid for multiple types influenza virus
Detection test by nucleic acid for mycobacteria avium-intracellulare (bacteria), amplified probe technique
Detection test by nucleic acid for mycobacteria species (bacteria), amplified probe technique
Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique
Detection test by nucleic acid for organism, amplified probe technique
Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
Detection test for candida species (yeast), amplified probe technique
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
This test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.
This service was performed 2,419 times for 763 patientsThis is a test that identifies various pathogens in your digestive tract by analyzing their genetic material, or nucleic acids. It can detect 12-25 different types or subtypes of pathogens, assisting in accurate diagnosis and treatment.
This service was performed 1,229 times for 763 patientsThis test identifies the presence of an enterovirus, a type of virus that primarily targets the digestive system. It uses a method called the amplified probe technique to boost the detection of the virus's genetic material, or nucleic acid.
This service was performed 1,215 times for 756 patientsThis test uses an amplified probe technique to identify the presence of the herpes simplex virus in your body. It works by detecting the virus's genetic material, or nucleic acid. The test is accurate, reliable, and can help in early detection and treatment.
This service was performed 2,431 times for 756 patientsA detection test for Legionella Pneumophila, a waterborne bacteria, uses the amplified probe technique. This involves identifying the bacteria's unique genetic material (nucleic acid) and amplifying it for easier detection, aiding in accurate diagnosis.
This service was performed 2,420 times for 763 patientsThis is a test that identifies various microorganisms in your body using a method called amplified probe technique. It targets specific genetic material (nucleic acids) of the organisms, amplifying them for easy detection. This helps in diagnosing infections accurately.
This service was performed 1,229 times for 757 patientsA detection test by nucleic acid for multiple types of influenza virus is a diagnostic procedure. It identifies the genetic material of the virus in your body. It's highly accurate and can distinguish between different flu strains, helping in prompt and precise treatment.
This service was performed 1,216 times for 756 patientsThis test identifies the presence of Mycobacteria Avium-Intracellulare, bacteria often linked with lung diseases. The amplified probe technique enhances the detection process by amplifying the bacteria's nucleic acid, making it easier to spot.
This service was performed 1,247 times for 759 patientsThis test identifies the presence of mycobacteria species, which can cause various infections including tuberculosis. It uses a technique called amplified probe, which magnifies the bacteria's nucleic acid, making it easier to detect.
This service was performed 1,247 times for 759 patientsThis test checks for Mycoplasma pneumoniae, a bacteria that can cause lung infection. It uses a method called amplified probe technique, which identifies the bacteria's genetic material. This helps in diagnosing the infection accurately.
This service was performed 2,419 times for 763 patientsA nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.
This service was performed 53,634 times for 765 patientsThis test identifies the presence of the Respiratory Syncytial Virus (RSV) in your body. It uses a technique called the amplified probe, which increases the amount of viral genetic material, making it easier to detect. This helps in diagnosing RSV infections accurately.
This service was performed 1,192 times for 755 patientsA detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.
This service was performed 3,623 times for 765 patientsThis test detects Group A Streptococcus bacteria in your body. It uses an amplified probe technique, which amplifies the bacteria's nucleic acid, making it easier to identify. This test helps diagnose conditions like strep throat or scarlet fever.
This service was performed 3,674 times for 765 patientsThis test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.
This service was performed 5,960 times for 764 patientsA definitive drug test identifies specific drugs in your system. It uses advanced methods like gc/ms and lc/ms, which can distinguish between different types of drugs but not necessarily their 3D forms. This test offers detailed results to support your healthcare decisions.
This service was performed 1,207 times for 750 patientsCLIA Information
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:
- CLIA Number
- 05D2270788
- Facility Type
- Independent
- Certificate Effective Date
- October 20, 2022
- Certificate Expiration Date
- May 31, 2026
- Laboratory Director
- SUNITA VEMPATI
- Certificate Type
- Certificate of Compliance
- Certificate Type Description
- This CLIA certificate is issued to G & M Labtesting Inc after an inspection that finds the laboratory to be in compliance with all applicable CLIA requirements. This type of certificate is issued to laboratories that perform nonwaived (moderate and/or high complexity) testing.
Reviews for G & M LABTESTING INC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1457036014, we treat the final digit (4) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 46. The final step is to find the difference between that total and the next multiple of ten (50 - 46 = 4).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 46 is 50. The difference is the calculated check digit.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1457036014, enumerated as an "organization" on June 20, 2023.
The provider is located at 7341 FOOTHILL BLVD STE 202 TUJUNGA, CA 91042 and the phone number is (747) 256-9745.
Clinical Medical Laboratory with taxonomy code 291U00000X.
